Updated Oct 27, 2026 · 09:24 UTC
GILDGilead Sciences, Inc.
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$157.84+1.70%last session · market early-hours
Market cap
$195.71b
real-world
Tokenized
$126
<0.001% of the asset
Avg token price
$158.58
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
GILD · Price
EarningsNasdaq’s earnings calendar
Next earnings
Oct 29
after the close · Sep 2026 quarter · EPS forecast $2.17 (6 analysts)
Last earnings, Aug 4
−$6.75 EPS
+4.5% vs −$7.07 forecast · Jun 2026 quarter
Real marketGilead Sciences Inc
Last close
$156.04
Oct 23
Traded on Oct 23
$949.8m
Price now
$157.84
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
wGILDxBacked Assets——Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$30.46b
+6% YoY
Operating income
−$2.50b
-8% margin
Net income
−$3.24b
-11% margin
EPS, diluted
−$2.61
Diluted shares
1.24b
−1% YoY
Cash and balance sheet
Free cash flow
$12.94b
42% of revenue · 6.6% yield
Quarterly
RevenueNet income
Valuation today’s market cap $195.71b
P/S
6.4×